7 News
·general
·4 hours ago
Eli Lilly’s Mounjaro fails to gain PBS listing, impacting 450,000 Australians
Eli Lilly’s diabetes and weight loss drug Mounjaro will not be listed on Australia’s PBS after negotiations with the federal government collapsed. Approximately 450,000 Australians will miss out on discounted access, forcing many to pay hundreds of dollars monthly. The medication's growing popularity has heightened concerns over accessibility for patients managing diabetes and weight.
Summary by Glance · 7 News
Newer
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI